Patent Attorney at Hanna Moore + Curley
Anna Hally is a European patent attorney, a UK chartered patent attorney, an Irish patent attorney and a Community design attorney with over 20 years’ experience in private practice.
Ms Hally’s career path has been varied and interesting, giving her a wide range of experiences to draw on. She graduated from Trinity College, Dublin, with an honours degree in natural sciences, specialising in genetics. This gave her a broad expertise in the field of natural science, with detailed experience and knowledge of a range of fields from biotechnology and molecular biology to plant science and biochemistry. In her final year, she carried out an extensive laboratory project at the Wellcome Ocular Genetics Laboratory, attempting to localise a gene for age-related macular degeneration. She added to her academic qualifications with a MSc in the management of intellectual property from the University of London.
Ms Hally spent almost a decade in London working in private practice before returning to Ireland. She joined Hanna Moore + Curley in 2017.
Ms Hally has experience dealing with clients ranging in size from university spin-out companies to major multinational companies. She practises in technologies in the general life sciences sector, including healthcare and pharmaceuticals, agritech, medtech and food technology on issues including drafting and prosecution of patent applications, supplementary protection certificates and plant variety rights, worldwide IP portfolio management/strategy, due diligence and opinion work. During her career, Ms Hally has been directly responsible for the patent portfolios of several major multinational companies. This unique insight into the workings of multinational corporations has added much to the breadth of her experience and expertise.
Ms Hally is a fellow of the UK Chartered Institute of Patent Attorneys and a member of the Irish Association of Patent and Trademark Attorneys. She is the Irish representative on the European Patent Institute Biotechnology Committee and a regular attendee of the BIO Convention. She has been regularly listed on IAM’s Patent 1000.